Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.2018.2493 ◽

2018 ◽

Vol 33 (10) ◽

pp. 421-426 ◽

Author(s):

Min Yu ◽

Qian Zhao ◽

Yanying Li ◽

Shuang Zhang ◽

Yong Xu ◽

...

Keyword(s):

Lung Cancer ◽

Central Nervous System ◽

Receptor Tyrosine Kinase ◽

First Generation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

Lung Cancer Patients ◽

Central Nervous System Metastases ◽

Epidermal Growth

Download Full-text

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2019.05.032 ◽

2019 ◽

Vol 117 ◽

pp. 107-115 ◽

Author(s):

Zong-Han Yao ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Intracavitary chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is not superior to TKI monotherapy in controlling malignant pleural effusion recurrence in EGFR-mutated lung cancer patients

Journal of Thoracic Disease ◽

10.21037/jtd.2019.09.36 ◽

2019 ◽

Vol 11 (9) ◽

pp. 3712-3720

Author(s):

Wenxian Wang ◽

Xiaowen Jiang ◽

Yiping Zhang ◽

Yong Song ◽

Zhengbo Song

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Malignant Pleural Effusion ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Lung Cancer Patients ◽

Intracavitary Chemotherapy ◽

Epidermal Growth ◽

Egfr Mutated ◽

Download Full-text

125P Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor

Annals of Oncology ◽

10.1016/j.annonc.2020.08.246 ◽

2020 ◽

Vol 31 ◽

pp. S290

Author(s):

Y-J. Zhu ◽

H-B. Zhang ◽

X-S. Chang ◽

Z-Z. Xiao ◽

L-R. Liu ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

The real world experience of first generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in patients with advanced lung cancer: Explorative analysis of big data from national health insurance service of Korea

Annals of Oncology ◽

10.1093/annonc/mdx091.027 ◽

2017 ◽

Vol 28 ◽

pp. ii39

Author(s):

B.S. Kwon ◽

J.C. Lee ◽

S. Kim ◽

M.Y. Kim ◽

C.-M. Choi

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Big Data ◽

Receptor Tyrosine Kinase ◽

First Generation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Advanced Lung Cancer ◽

Epidermal Growth ◽

Download Full-text

Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer

Journal of the Chinese Medical Association ◽

10.1016/j.jcma.2016.01.008 ◽

2016 ◽

Vol 79 (5) ◽

pp. 248-255 ◽

Author(s):

Chi-Lu Chiang ◽

Yi-Wei Chen ◽

Mei-Han Wu ◽

Hsu-Ching Huang ◽

Chun-Ming Tsai ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

Radiation Recall ◽

Epidermal Growth ◽

Recall Pneumonitis

Download Full-text

Retraction: Biao Gu, Jipeng Wang, Yaqi Song, Qi Wang, and Qingquan Wu, The prognosis analysis of epidermal growth factor receptor tyrosine kinase inhibitor targeted treatment combined with chemotherapy in smokers with nonsmall cell lung cancer. J. Cell. B

Journal of Cellular Biochemistry ◽

10.1002/jcb.28335 ◽

2019 ◽

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

Epidermal Growth

Download Full-text

Retracted : The prognosis analysis of epidermal growth factor receptor tyrosine kinase inhibitor targeted treatment combined with chemotherapy in smokers with nonsmall cell lung cancer

Journal of Cellular Biochemistry ◽

10.1002/jcb.27811 ◽

2018 ◽

Vol 120 (5) ◽

pp. 8798-8798

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

Epidermal Growth

Download Full-text

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review

10.1186/s12885-019-5309-x ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Takuma Imakita ◽

Hirotaka Matsumoto ◽

Katsuya Hirano ◽

Toshiyuki Morisawa ◽

Azusa Sakurai ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer

Cancer ◽

10.1002/cncr.24877 ◽

2010 ◽

Vol 116 (5) ◽

pp. 1336-1343 ◽

Author(s):

Young Joo Lee ◽

Hye Jin Choi ◽

Se Kyu Kim ◽

Joon Chang ◽

Jin Wook Moon ◽

...

Keyword(s):

Lung Cancer ◽

Central Nervous System ◽

Nervous System ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

System Failure ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases

Chronic Diseases and Translational Medicine ◽

10.1016/j.cdtm.2017.11.001 ◽

2017 ◽

Vol 3 (4) ◽

pp. 221-229 ◽

Author(s):

Ling-Ling Kong ◽

Lin-Lin Wang ◽

Li-Gang Xing ◽

Jin-Ming Yu

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Tyrosine Kinase Inhibitor Therapy ◽

Epidermal Growth

Download Full-text